Biologics Market: By Source (Microbial, Mammalia Others), By Product (MABs, Vaccine, Hormones, Therapeutic Enzymes, Recombinant Proteins, Antisense, RNAi & Molecular Therapy, Blood Factors and Anticoagulants, Allergenic extracts, Human Cells and Tissues, Proteins, Gene Therapies, Cellular Therapies Others), By Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders Others), By Drug Classification (Branded Drugs, Generic Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography.

Purchase Option

Single User License $ 4400

Multiple User License $ 6600

Corporate User License $ 8900

1. Executive Summary

2. Global Biologics Market Introduction

2.1. Global Biologics Market – Taxonomy

2.2. Global Biologics Market –Definitions

2.2.1. By Source

2.2.2. By Product

2.2.3. By Disease

2.2.4. By Drug Classification

2.2.5. By Distribution Channel

2.2.6. By Region

3. Global Biologics Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Biologics Market Dynamic Factors - Impact Analysis

3.6. Global Biologics Market – Competition Landscape

4. Global Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029

4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Biologics Market, By Source, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

5.1. Microbial

5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Mammalian

5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Others

5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

6. Global Biologics Market, By Product, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.1. MABs

6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Vaccines

6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Hormones

6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Therapeutic Enzymes

6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Recombinant Proteins

6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

6.6. Antisense, RNAi & Molecular Therapy

6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.6.3. Market Opportunity Analysis

6.7. Blood Factors and Anticoagulants

6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.7.3. Market Opportunity Analysis

6.8. Allergenic extracts

6.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.8.3. Market Opportunity Analysis

6.9. Human Cells and Tissues

6.9.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.9.3. Market Opportunity Analysis

6.10. Proteins

6.10.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.10.3. Market Opportunity Analysis

6.11. Gene Therapies

6.11.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.11.3. Market Opportunity Analysis

6.12. Cellular Therapies

6.12.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.12.3. Market Opportunity Analysis

6.13. Others

6.13.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.13.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.13.3. Market Opportunity Analysis

7. Global Biologics Market, By Disease, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.1. Oncology

7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Immunological Disorders

7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Cardiovascular Disorders

7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Hematological Disorders

7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Others

7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

8. Global Biologics Market Forecast, By Drug Classification, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.1. Branded Drugs

8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Generic Drugs

8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

9. Global Biologics Market Forecast, By Distribution Channel, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.1. Hospital Pharmacies

9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Retail Pharmacies

9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Online Pharmacies

9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

10. Global Biologics Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

10.1. North America

10.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.1.3. Market Opportunity Analysis

10.2. Europe

10.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.2.3. Market Opportunity Analysis

10.3. Asia-Pacific

10.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.3.3. Market Opportunity Analysis

10.4. Latin America

10.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.4.3. Market Opportunity Analysis

10.5. Middle East and Africa

10.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.5.3. Market Opportunity Analysis

10.6. Global Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Region, 2023-2029

11. North America Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

11.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Microbial

11.1.2. Mammalian

11.1.3. Others

11.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. MABs

11.2.2. Vaccines

11.2.3. Hormones

11.2.4. Therapeutic Enzymes

11.2.5. Recombinant Proteins

11.2.6. Antisense, RNAi & Molecular Therapy

11.2.7. Blood Factors and Anticoagulants

11.2.8. Allergenic extracts

11.2.9. Human Cells and Tissues

11.2.10. Proteins

11.2.11. Gene Therapies

11.2.12. Cellular Therapies

11.2.13. Others

11.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Oncology

11.3.2. Immunological Disorders

11.3.3. Cardiovascular Disorders

11.3.4. Hematological Disorders

11.3.5. Others

11.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.4.1. Branded Drugs

11.4.2. Generic Drugs

11.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online Pharmacies

11.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.6.1. USA

11.6.2. Canada

11.7. North America Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029

11.8. North America Biologics Market Dynamics – Trends

12. Europe Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

12.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Microbial

12.1.2. Mammalian

12.1.3. Others

12.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. MABs

12.2.2. Vaccines

12.2.3. Hormones

12.2.4. Therapeutic Enzymes

12.2.5. Recombinant Proteins

12.2.6. Antisense, RNAi & Molecular Therapy

12.2.7. Blood Factors and Anticoagulants

12.2.8. Allergenic extracts

12.2.9. Human Cells and Tissues

12.2.10. Proteins

12.2.11. Gene Therapies

12.2.12. Cellular Therapies

12.2.13. Others

12.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Oncology

12.3.2. Immunological Disorders

12.3.3. Cardiovascular Disorders

12.3.4. Hematological Disorders

12.3.5. Others

12.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.4.1. Branded Drugs

12.4.2. Generic Drugs

12.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.5.1. Hospital Pharmacies

12.5.2. Retail Pharmacies

12.5.3. Online Pharmacies

12.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.6.1. Germany

12.6.2. UK

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Russia

12.6.7. Rest of Europe

12.7. Europe Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029

12.8. Europe Biologics Market Dynamics – Trends

13. Asia-Pacific Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

13.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Microbial

13.1.2. Mammalian

13.1.3. Others

13.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. MABs

13.2.2. Vaccines

13.2.3. Hormones

13.2.4. Therapeutic Enzymes

13.2.5. Recombinant Proteins

13.2.6. Antisense, RNAi & Molecular Therapy

13.2.7. Blood Factors and Anticoagulants

13.2.8. Allergenic extracts

13.2.9. Human Cells and Tissues

13.2.10. Proteins

13.2.11. Gene Therapies

13.2.12. Cellular Therapies

13.2.13. Others

13.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Oncology

13.3.2. Immunological Disorders

13.3.3. Cardiovascular Disorders

13.3.4. Hematological Disorders

13.3.5. Others

13.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.4.1. Branded Drugs

13.4.2. Generic Drugs

13.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.5.1. Hospital Pharmacies

13.5.2. Retail Pharmacies

13.5.3. Online Pharmacies

13.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.6.1. China

13.6.2. India

13.6.3. Japan

13.6.4. ASEAN

13.6.5. Australia & New Zealand

13.6.6. Rest of Asia-Pacific

13.7. Asia-Pacific Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029

13.8. Asia-Pacific Biologics Market Dynamics – Trends

14. Latin America Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

14.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Microbial

14.1.2. Mammalian

14.1.3. Others

14.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.2.1. MABs

14.2.2. Vaccines

14.2.3. Hormones

14.2.4. Therapeutic Enzymes

14.2.5. Recombinant Proteins

14.2.6. Antisense, RNAi & Molecular Therapy

14.2.7. Blood Factors and Anticoagulants

14.2.8. Allergenic extracts

14.2.9. Human Cells and Tissues

14.2.10. Proteins

14.2.11. Gene Therapies

14.2.12. Cellular Therapies

14.2.13. Others

14.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.3.1. Oncology

14.3.2. Immunological Disorders

14.3.3. Cardiovascular Disorders

14.3.4. Hematological Disorders

14.3.5. Others

14.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.4.1. Branded Drugs

14.4.2. Generic Drugs

14.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.5.1. Hospital Pharmacies

14.5.2. Retail Pharmacies

14.5.3. Online Pharmacies

14.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029

14.8. Latin America Biologics Market Dynamics – Trends

15. Middle East and Africa Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

15.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

15.1.1. Microbial

15.1.2. Mammalian

15.1.3. Others

15.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

15.2.1. MABs

15.2.2. Vaccines

15.2.3. Hormones

15.2.4. Therapeutic Enzymes

15.2.5. Recombinant Proteins

15.2.6. Antisense, RNAi & Molecular Therapy

15.2.7. Blood Factors and Anticoagulants

15.2.8. Allergenic extracts

15.2.9. Human Cells and Tissues

15.2.10. Proteins

15.2.11. Gene Therapies

15.2.12. Cellular Therapies

15.2.13. Others

15.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

15.3.1. Oncology

15.3.2. Immunological Disorders

15.3.3. Cardiovascular Disorders

15.3.4. Hematological Disorders

15.3.5. Others

15.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

15.4.1. Branded Drugs

15.4.2. Generic Drugs

15.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

15.5.1. Hospital Pharmacies

15.5.2. Retail Pharmacies

15.5.3. Online Pharmacies

15.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

15.6.1. Gulf Cooperation Council (GCC) Countries

15.6.2. South Africa

15.6.3. Rest of MEA

15.7. MEA Biologics Market - Opportunity Analysis Index By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029

15.8. MEA Biologics Market Dynamics – Trends

16. Competition Landscape

16.1. Strategic Dashboard of Top Market Players

16.2. Company Profiles (Introduction, Financial Analysis, Key Sources, Key Developments, Strategies, and SWOT Analysis)

16.2.1. AbbVie Inc.

16.2.2. Amgen Inc.

16.2.3. AstraZeneca plc

16.2.4. F. Hoffmann-La Roche Ltd

16.2.5. GlaxoSmithKline plc

16.2.6. Johnson & Johnson

16.2.7. Merck KGaA

16.2.8. Novartis AG

16.2.9. Pfizer Inc.

16.2.10. Sanofi

17. Research Methodology

18. Key Assumptions and Acronyms

Key Features of the Reports

The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Frequently Asked Questions

The biologics market key players are: AbbVie Inc., Amgen Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Hoffmann-La Roche Ltd

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.